Clinical trial
A Phase I Trial of Myeloablative Conditioning w/ Clofarabine and HD Busulfan for…
NCT00477542 · Indiana University School of Medicine, Other · Completed
Key facts
| NCT number | NCT00477542 |
|---|---|
| Title | A Phase I Trial of Myeloablative Conditioning w/ Clofarabine and HD Busulfan for Pts w/ Refractory Heme Malignancies Undergoing Allo PBSCT |
| Official title | A Phase I Trial of Myeloablative Conditioning Using Clofarabine and High-Dose Busulfan for Patients With Refractory Hematological Malignancies Undergoing Allogeneic HSCT |
| Lead sponsor | Indiana University School of Medicine, Other |
| Collaborators | Genzyme, a Sanofi Company Industry |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Hematologic Malignancies |
| Intervention type | Drug |
| Interventions | clofarabine |
| Enrollment | 18 |
| Start date | May 1, 2007 |
| Primary completion | Nov 1, 2010 |
| Completion | Nov 1, 2010 |
| First posted | May 23, 2007 |
| Last update posted | Sep 18, 2014 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: